FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, in particular to an artificially modified immune system having an increased immune effect. The invention allows for producing an immune cell with modified functions, containing modified immunoregulatory genes DGKα and DGKζ.
EFFECT: invention has increased therapeutic efficiency compared to known analogues; it can be used in medicine, in particular in adoptive immunotherapy.
17 cl, 8 ex, 6 tbl, 18 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ARTIFICIAL GENOME MODIFICATION FOR GENE EXPRESSION REGULATION | 2018 |
|
RU2767201C2 |
| ARTIFICIALLY CREATED SC FUNCTION CONTROL SYSTEM | 2017 |
|
RU2768043C2 |
| HSD17B13 OPTIONS AND THEIR APPLICATIONS | 2018 |
|
RU2760851C2 |
| RNA-GUIDED HUMAN GENOME ENGINEERING | 2013 |
|
RU2766685C2 |
| CRISPR-CAS SYSTEMS AND METHODS FOR CHANGING THE EXPRESSION OF GENE PRODUCTS | 2013 |
|
RU2796273C2 |
| DELIVERY, CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND USE IN THERAPY | 2013 |
|
RU2721275C2 |
| DELIVERY, USE AND USE IN THERAPY OF CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETED ACTION ON DISORDERS AND DISEASES USING VIRAL COMPONENTS | 2014 |
|
RU2716421C2 |
| DELIVERY, CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED ACTION AND MODELING OF DISEASES AND DISORDERS OF POSTMITOTIC CELLS | 2014 |
|
RU2725502C2 |
| GENE EDITING USING MODIFIED CLOSED-END DNA (ceDNA) | 2018 |
|
RU2811724C2 |
| COMPONENTS OF THE CRISPR-CAS SYSTEM, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | 2013 |
|
RU2796549C2 |
